Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vivinox is a brand of over-the-counter (OTC) pharmaceutical products developed by Dr. Gerhard Mann (a subsidiary of Bausch + Lomb) primarily indicated for the short-term treatment of sleep disorders and nervous restlessness. The product line includes **Vivinox Sleep**, which utilizes **diphenhydramine hydrochloride**, a first-generation antihistamine that acts as an antagonist at the histamine H1 receptor to induce sedation. The brand also encompasses herbal formulations, such as **Vivinox Nervenruhe**, which contain extracts of **valerian root**, **lemon balm**, and **passionflower**. These herbal components are traditionally used to alleviate restlessness and facilitate sleep, likely through the modulation of GABAergic signaling in the central nervous system. These products are marketed in Germany as pharmacy-only medications for symptomatic relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vivinox.